December 14, 2019

AND YOU THOUGHT THE SCIENCE WAS SETTLED: “The ongoing debate about postmenopausal hormone therapy and breast cancer risk may have turned even more muddy: A large, new study suggests that two different types of hormone therapy have opposite effects on women’s long-term risk of the disease. The researchers found that combined hormone replacement therapy — with estrogen and progestin — increases the risk of breast cancer, with effects that last for years after women discontinue the therapy. On the other hand, women who take estrogen alone appear to have an equally long-lasting decrease in their breast cancer risk.”

What I find interesting is that there’s far more expressed concern about the side effects of hormone therapy — for both men and women — that’s designed to help them feel normal, but virtually none about the much less natural doses of hormones used in sex transition treatments.

InstaPundit is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.